Stress and its effects on glucose metabolism and 11 β -HSD activities in rats fed on a combination of high-fat and high-sucrose diet with glycyrrhizic acid

Journal of Diabetes Research

Volumn 2013, Issue , 2013, Pages

  Fernando, Hamish Alexander ^a   Chin, Hsien Fei ^a   Ton, So Ha ^a   Abdul Kadir, Khalid ^a  

^a MONASH UNIVERSITY MALAYSIA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; 11BETA HYDROXYSTEROID DEHYDROGENASE 2; ADRENALIN; CORTICOSTERONE; GLUCOCORTICOID; GLUCOSE; GLYCYRRHIZIC ACID; INSULIN; SUCROSE;

ADAPTATION; ADRENALIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CORTICOSTERONE BLOOD LEVEL; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INSULIN BLOOD LEVEL; LIPID DIET; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS; SUBCUTANEOUS FAT; SYSTOLIC BLOOD PRESSURE;

EID: 84879325962     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2013/190395     Document Type: Article

References (100)

1. Eckel R. H., Grundy S. M., Zimmet P. Z., The metabolic syndrome. The Lancet 2005 365 9468 1415 1428 2-s2.0-17144380822 10.1016/S0140-6736(05)66378-7 (Pubitemid 40523737)
2. Alberti K. G. M. M., Zimmet P., Shaw J., Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabetic Medicine 2006 23 5 469 480 2-s2.0-33645978121 10.1111/j.1464-5491.2006.01858.x
3. Panchal S. K., Poudyal H., Iyer A., Nazer R., Alam A., Diwan V., Kauter K., Sernia C., Campbell F., Ward L., Gobe G., Fenning A., Brown L., High-carbohydrate high-fat diet-induced metabolic syndrome and cardiovascular remodeling in rats. Journal of Cardiovascular Pharmacology 2011 57 1 51 64 2-s2.0-78951477257 10.1097/FJC.0b013e3181feb90a
4. Stinnett G. S., Seasholtz A. F., Koob G. F., Le Moal M., Thompson R. F., Stress and emotionality. Encyclopedia of Behavioral Neuroscience 2010 Elsevier 316 321
5. Ruszymah B. H., Khalid B. A., A survey of recent results concerning glycyrrhizic acid in stress and adaptation. Medical Journal of Islamic Academy of Sciences 1999 12 1 25 28
6. Sterling P., Eyer J., Fisher S., Reason J., Allostasis: a new paradigm to explain arousal pathology. Handbook of Life Stress, Cognition and Health 1988 New York, NY, USA John Wiley & Sons 631 651
7. Björntorp P., Do stress reactions cause abdominal obesity and comorbidities? Obesity Reviews 2001 2 2 73 86 2-s2.0-0035342367 (Pubitemid 33755917)
8. Chrousos G. P., Gold P. W., Schmidt L. A., Schulkin J., The inhibited child syndrome. Thoughts on its potential pathogenesis and sequelae. Extreme Fear, Shyness and Social Phobia: Origins, Biological Mechanisms and Clinical Outcomes 1999 Stockholm, Sweden Informa Healthcare 193 200
9. Pervanidou P., Chrousos G. P., Post-traumatic stress disorder in children and adolescents: from Sigmund Freud's Trauma to psychopathology and the (Dys)metabolic syndrome. Hormone and Metabolic Research 2007 39 6 413 419 2-s2.0-34347218935 10.1055/s-2007-981461 (Pubitemid 46999847)
10. Rosmond R., Role of stress in the pathogenesis of the metabolic syndrome. Psychoneuroendocrinology 2005 30 1 1 10 2-s2.0-4444269459 10.1016/j.psyneuen. 2004.05.007 (Pubitemid 39195039)
11. Björntorp P., Body fat distribution, insulin resistance, and metabolic diseases. Nutrition 1997 13 9 795 803 2-s2.0-0343683306 10.1016/S0899-9007(97)00191-3 (Pubitemid 27382449)
12. Tomlinson J. W., Walker E. A., Bujalska I. J., Draper N., Lavery G. G., Cooper M. S., Hewison M., Stewart P. M., 11 β -Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocrine Reviews 2004 25 5 831 866 2-s2.0-4043077286 10.1210/er.2003-0031 (Pubitemid 39366049)
13. Ploeger B., Mensinga T., Sips A., Seinen W., Meulenbelt J., DeJongh J., The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling. Drug Metabolism Reviews 2001 33 2 125 147 2-s2.0-0034900215 10.1081/DMR-100104400 (Pubitemid 32703253)
14. Peckett A. J., Wright D. C., Riddell M. C., The effects of glucocorticoids on adipose tissue on lipid metabolism. Metabolism Clinical and Experimental 2011 60 1500 1510
15. Schlingmann F. S., De Rijk H. L., Pereboom W. J., Remie R., Avoidance as a behavioural parameter in the determination of distress amongst albino and pigmented rats at various light intensities. Animal Technology 1993 44 2 87 96
16. Vanderschuren L. J. M., Niesink R. J. M., Spruijt B. M., Van Ree J. M., Influence of environmental factors on social play behavior of juvenile rats. Physiology and Behavior 1995 58 1 119 123 2-s2.0-0029037601 10.1016/0031- 9384(94)00385-I
17. Matsuo M., Tsuji K., Strain differences of the light-dark preference in inbred rats. Behavior Genetics 1989 19 3 457 466 2-s2.0-0024659822 10.1007/BF01066171
18. Williams R. A., Howard A. G., Williams T. P., Retinal damage in pigmented and albino rats exposed to low levels of cyclic light following a single mydriatic treatment. Current Eye Research 1985 4 2 97 102 2-s2.0-0021972577 (Pubitemid 15171827)
19. Freeman M. E., Kanyicska B., Lerant A., Nagy G., Prolactin: structure, function and regulation of secretion. Physiology Reviews 2000 80 1523 1621
20. Wong M. A., Oace S. M., Feeding pattern and gastrointestinal transit rate of rats under different room lighting schedules. Laboratory Animal Science 1981 31 4 362 365 2-s2.0-0019784852 (Pubitemid 12228163)
21. McEachron D. L., Tumas K. M., Blank K. J., Prystowsky M. B., Environmental lighting alters the infection process in an animal model of AIDS. Pharmacology Biochemistry and Behavior 1995 51 4 947 952 2-s2.0-0028981687 10.1016/0091-3057(95)00031-Q
22. Blake C. A., Effects of pinealectomy on the rat oestrous cycle and pituitary gonadotrophin release. Journal of Endocrinology 1976 69 1 67 75 2-s2.0-0017182578
23. Dauchy R. T., Sauer L. A., Blask D. E., Vaughan G. M., Light contamination during the dark phase in photoperiodically controlled animal rooms: effect on tumor growth and metabolism in rats. Laboratory Animal Science 1997 47 5 511 518 2-s2.0-0031421835
24. Chandramouli C., Yong S. T., Lam Y. L., Ton S. H., Khalid B. A., Glycyrrhizic acid improves lipid and glucose metabolism in high-sucrose-fed rats. Journal of Endocrinology and Metabolism 2011 1 3 125 141
25. Eu C. H. A., Lim W. Y. A., Ton S. H., Khalid B. A., Glycyrrhizic acid improved lipoprotein lipase expression, insulin sensitivity, serum lipid and lipid deposition in high-fat diet-induced obese rats. Lipids in Health and Disease 2010 9, article 81 2-s2.0-77954997237 10.1186/1476-511X-9-81
26. Esler M., Jackman G., Bobik A., Determination of norepinephrine apparent release rate and clearance in humans. Life Sciences 1979 25 17 1461 1470 2-s2.0-0018576307 10.1016/0024-3205(79)90371-0 (Pubitemid 10204594)
27. Venkataraman S., Munoz R., Candido C., Witchel S. F., The hypothalamic-pituitary-adrenal axis in critical illness. Reviews in Endocrine and Metabolic Disorders 2007 8 4 365 373 2-s2.0-38049015993 10.1007/s11154-007- 9058-9
28. Ainsah O., Nabishah B. M., Osman C. B., Khalid B. A. K., Effects of naloxone, glycyrrhizic acid, dexamethasone and deoxycorticosterone in repetitive stress. Clinical and Experimental Pharmacology and Physiology 1999 26 5-6 433 437 2-s2.0-0033051269 10.1046/j.1440-1681.1999.03052.x (Pubitemid 29306961)
29. Ainsah O., Nabishah B. M., Osman C. B., Khalid B. A. K., Short- and long-term effects of glycyrrhizic acid in repetitive stress. Clinical and Experimental Pharmacology and Physiology 1999 26 5-6 444 448 2-s2.0-0033015378 10.1046/j.1440-1681.1999.03064.x (Pubitemid 29306963)
30. Altuna M. E., Lelli S. M., San Martín De Viale L. C., Damasco M. C., Effect of stress on hepatic 11 β -hydroxysteroid dehydrogenase activity and its influence on carbohydrate metabolism. Canadian Journal of Physiology and Pharmacology 2006 84 10 977 984 2-s2.0-33846950073 10.1139/Y06-046
31. Farihah S. H., Nabishah B. M., Khalid B. A., Isoprenaline reverses glycyrrhizic acid-induced inhibition of 11-hydroxysteroid dehydrogenase bioactivity. Pakistan Journal of Nutrition 2006 5 6 544 547 2-s2.0-33845682585 10.3923/pjn.2006.544.547
32. Lichtenstein M. J., Shipley M. J., Rose G., Systolic and diastolic blood pressures as predictors of coronary heart disease mortality in the Whitehall study. British Medical Journal 1985 291 6490 243 245 2-s2.0-0021884405 (Pubitemid 15045052)
33. Dressler W. W., Modernization, stress, and blood pressure: new directions in research. Human Biology 1999 71 4 583 605 2-s2.0-0033179832 (Pubitemid 29384619)
34. Van Uum S. H. M., Hermus A. R. M. M., Smits P., Thien T., Lenders J. W. M., The role of 11 β -hydroxysteroid dehydrogenase in the pathogenesis of hypertension. Cardiovascular Research 1998 38 1 16 24 2-s2.0-0032051655 10.1016/S0008-6363(97)00299-X (Pubitemid 28275613)
35. Pauline M., Avadhany S. T., Maruthy K. N., Non invasive measurement of systolic blood pressure in rats: a simple technique. Al Ameen Journal of Medical Science 2011 4 4 365 369
36. Depres-Brummer P., Levi F., Metzger G., Touitou Y., Light-induced suppression of the rat circadian system. American Journal of Physiology 1995 268 5 R1111 R1116 2-s2.0-0029009658
37. Vilaplana J., Cambras T., Diez-Noguera A., Effects of light intensity on the activity rhythm of young rats. Biological Rhythm Research 1995 26 3 306 315
38. Witte K., Lemmer B., Free-running rhythms in blood pressure, heart rate, and motor activity in normotensive and transgenic hypertensive rats. Chronobiology International 1995 12 237 247
39. Witting W., Boerma D., Koster-Van Hoffen G. C., Swaab D. F., Mirmiran M., Light suppresses frequency and endogenous amplitude of the circadian system in nocturnal animals. Biological Rhythm Research 1995 26 5 477 485 2-s2.0-0029201293 (Pubitemid 3009912)
40. Briaud S. A., Zhang B. L., Sannajust F., Continuous light exposure and sympathectomy suppress circadian rhythm of blood pressure in rats. Journal of Cardiovascular Pharmacology and Therapeutics 2004 9 2 97 105 2-s2.0-4043178614 10.1177/107424840400900205 (Pubitemid 39071595)
41. Pandi-Perumal S. R., Srinivasan V., Maestroni G. J. M., Cardinali D. P., Poeggeler B., Hardeland R., Melatonin: nature's most versatile biological signal? FEBS Journal 2006 273 13 2813 2838 2-s2.0-33745205104 10.1111/j.1742-4658.2006.05322.x
42. Zanoboni A., Zanoboni-Muciaccia W., Experimental hypertension in pinealectomized rats. Life Sciences 1967 6 21 2327 2331 2-s2.0-0014145872
43. Gallara R. V., Bellavia S. L., Serova L. L., Sabban E. L., Environmental light conditions alter gene expression of rat catecholamine biosynthetic enzymes and Neuropeptide Y: differential effect in superior cervical ganglia and adrenal gland. Molecular Brain Research 2004 124 2 152 158 2-s2.0-2342488733 10.1016/j.molbrainres.2004.02.012 (Pubitemid 38591567)
44. Morimoto A., Watanabe T., Morimoto K., Nakamori T., Murakami N., Possible involvement of prostaglandins in psychological stress-induced responses in rats. Journal of Physiology 1991 443 421 429 2-s2.0-0026002004
45. Handy D. E., Johns C., Bresnahan M. R., Tavares A., Bursztyn M., Gavras H., Expression of α 2-adrenergic receptors in normal and atherosclerotic rabbit aorta. Hypertension 1998 32 2 311 317 2-s2.0-0031594997 (Pubitemid 28376490)
46. Kvetnansky R., Fukuhara K., Pacak K., Cizza G., Goldstein D. S., Kopin I. J., Endogenous glucocorticoids restrain catecholamine synthesis and release at rest and during immobilization stress in rats. Endocrinology 1993 133 3 1411 1419 2-s2.0-0027236948 10.1210/en.133.3.1411 (Pubitemid 23267800)
47. Andrews R. C., Rooyackers O., Walker B. R., Effects of the 11 β -hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes. The Journal of Clinical Endocrinology and Metabolism 2003 88 1 285 291 2-s2.0-0037238379 10.1210/jc.2002-021194 (Pubitemid 36115179)
48. Cassuto H., Kochan K., Chakravarty K., Cohen H., Blum B., Olswang Y., Hakimi P., Xu C., Massillon D., Hanson R. W., Reshef L., Glucocorticoids regulate transcription of the gene for phosphoenolpyruvate carboxykinase in the liver via an extended glucocorticoid regulatory unit. The Journal of Biological Chemistry 2005 280 40 33873 33884 2-s2.0-26644472453 10.1074/jbc.M504119200 (Pubitemid 41443107)
49. Vegiopoulos A., Herzig S., Glucocorticoids, metabolism and metabolic diseases. Molecular and Cellular Endocrinology 2007 275 1-2 43 61 2-s2.0-34547885436 10.1016/j.mce.2007.05.015 (Pubitemid 47259280)
50. Barth E., Albuszies G., Baumgart K., Matejovic M., Wachter U., Vogt J., Radermacher P., Calzia E., Glucose metabolism and catecholamines. Critical Care Medicine 2007 35 9 S508 S518 2-s2.0-34548163166 10.1097/01.CCM.0000278047.06965. 20 (Pubitemid 47312187)
51. Niijima A., Nagai K., Nagai N., Nakagawa H., Light enhances sympathetic and suppresses vagal outflows and lesions including the suprachiasmatic nucleus eliminate these changes in rats. Journal of the Autonomic Nervous System 1992 40 2 155 160 2-s2.0-0026669008 10.1016/0165-1838(92)90026-D
52. Alberts P., Nilsson C., Selén G., Engblom L. O. M., Edling N. H. M., Norling S., Klingström G., Larsson C., Forsgren M., Ashkzari M., Nilsson C. E., Fiedler M., Bergqvist E., Öhman B., Björkstrand E., Abrahmsén L. B., Selective inhibition of 11 β -hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains. Endocrinology 2003 144 11 4755 4762 2-s2.0-0242468543 10.1210/en.2003-0344 (Pubitemid 37378389)
53. Saltiel A. R., Kahn C. R., Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001 414 6865 799 806 2-s2.0-0035856949 10.1038/414799a (Pubitemid 34000783)
54. Kim H. I., Ahn Y. H., Role of peroxisome proliferator-activated receptor- γ in the glucose-sensing apparatus of liver and β -cells. Diabetes 2004 53 supplement 1 S60 S65 2-s2.0-0842263985
55. Xu Z. K., Chen N. G., Ma C. Y., Meng Z. X., Sun Y. J., Han X., Role of peroxisome proliferator-activated receptor gamma in glucose-induced insulin secretion. Acta Biochimica et Biophysica Sinica 2006 38 1 1 7 2-s2.0-33644832527 10.1111/j.1745-7270.2006.00128.x (Pubitemid 43357038)
56. Burén J., Bergström S. A., Loh E., Söderström I., Olsson T., Mattsson C., Hippocampal 11 β -hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression has a diurnal variability that is lost in the obese zucker rat. Endocrinology 2007 148 6 2716 2722 2-s2.0-34250799911 10.1210/en.2006-0897 (Pubitemid 46984787)
57. Van den Berghe G., The role of the liver in metabolic homeostasis: implications for inborn errors of metabolism. Journal of Inherited Metabolic Disease 1991 14 4 407 420 2-s2.0-0025768055
58. Seckl J. R., Walker B. R., Minireview: 11 β -hydroxysteroid dehydrogenase type 1-a tissue-specific amplifier of glucocorticoid action. Endocrinology 2001 142 4 1371 1376 2-s2.0-0034744614 10.1210/en.142.4.1371 (Pubitemid 32299662)
59. Khani S., Tayek J. A., Cortisol increases gluconeogenesis in humans: its role in the metabolic syndrome. Clinical Science 2001 101 6 739 747 2-s2.0-0035214605 10.1042/CS20010180 (Pubitemid 33135358)
60. Brown R. W., Chapman K. E., Edwards C. R. W., Seckl J. R., Human placental 11 β -hydroxysteroid dehydrogenase: evidence for and partial purification of a distinct NAD-dependent isoform. Endocrinology 1993 132 6 2614 2621 2-s2.0-0027159080 10.1210/en.132.6.2614 (Pubitemid 23156917)
61. Jamieson P. M., Chapman K. E., Seckl J. R., Tissue- and temporal-specific regulation of 11 β -hydroxysteroid dehydrogenase type 1 by glucocorticoids in vivo. Journal of Steroid Biochemistry and Molecular Biology 1999 68 5-6 245 250 2-s2.0-0033000632 10.1016/S0960-0760(99)00037-0 (Pubitemid 29290661)
62. Farihah S. H., Nabishah B. M., Khalid B. A., Effect of corticosteroids and glycyrrhizic acid on the bioactivity of 11B-hydroxysteroid dehydrogenase in repetitive stress. Proceedings of the 11th International Congress of Endocrinology 2000 76
63. Paternain L., García-Diaz D. F., Milagro F. I., González-Muniesa P., Martinez J. A., Campión J., Regulation by chronic-mild stress of glucocorticoids, monocyte chemoattractant protein-1 and adiposity in rats fed on a high-fat diet. Physiology and Behavior 2011 103 2 173 180 2-s2.0-79952767491 10.1016/j.physbeh.2011.01.017
64. Gong R., Morris D. J., Brem A. S., Variable expression of 11 β Hydroxysteroid dehydrogenase (11 β -HSD) isoforms in vascular endothelial cells. Steroids 2008 73 11 1187 1196 2-s2.0-46749128450 10.1016/j.steroids.2008. 05.009
65. Tsugita M., Iwasaki Y., Nishiyama M., Taguchi T., Shinahara M., Taniguchi Y., Kambayashi M., Terada Y., Hashimoto K., Differential regulation of 11 β -hydroxysteroid dehydrogenase type-1 and -2 gene transcription by proinflammatory cytokines in vascular smooth muscle cells. Life Sciences 2008 83 11-12 426 432 2-s2.0-50849145155 10.1016/j.lfs.2008.07.005
66. Roland B. L., Krozowski Z. S., Funder J. W., Glucocorticoid receptor, mineralocorticoid receptors, 11 β -hydroxysteroid dehydrogenase-1 and -2 expression in rat brain and kidney: in situ studies. Molecular and Cellular Endocrinology 1995 111 1 R1 R7 2-s2.0-0029065303 10.1016/0303-7207(95)03559-P
67. Elliot W. H., Elliot D. C., Biochemistry and Molecular Biology 2005 3rd Oxford, UK Oxford University Press
68. Meyer C., Stumvoll M., Nadkarni V., Dostou J., Mitrakou A., Gerich J., Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus. Journal of Clinical Investigation 1998 102 3 619 624 2-s2.0-0032146567 (Pubitemid 28376164)
69. Quinkler M., Troeger H., Eigendorff E., Maser-Gluth C., Stiglic A., Oelkers W., Bähr V., Diederich S., Enhanced 11 β -hydroxysteroid dehydrogenase type 1 activity in stress adaptation in the guinea pig. Journal of Endocrinology 2003 176 2 185 192 2-s2.0-0037291642 10.1677/joe.0.1760185 (Pubitemid 36284811)
70. Livingstone D. E. W., Jones G. C., Smith K., Jamieson P. M., Andrew R., Kenyon C. J., Walker B. R., Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 2000 141 2 560 563 2-s2.0-0034463972 10.1210/en.141.2.560 (Pubitemid 32250479)
71. Albiston A. L., Obeyesekere V. R., Smith R. E., Krozowski Z. S., Cloning and tissue distribution of the human 11 β -hydroxysteroid dehydrogenase type 2 enzyme. Molecular and Cellular Endocrinology 1994 105 2 R11 R17 2-s2.0-0028034209 10.1016/0303-7207(94)90176-7
72. Rusvai E., Naray-Fejes-Toth A., A new isoform of 11 β -hydroxysteroid dehydrogenase in aldosterone target cells. The Journal of Biological Chemistry 1993 268 15 10717 10720 2-s2.0-0027162955 (Pubitemid 23162245)
73. Stewart P. M., Whorwood C. B., Mason J. I., Type 2 11 β -hydroxysteroid dehydrogenase in foetal and adult life. Journal of Steroid Biochemistry and Molecular Biology 1995 55 5-6 465 471 2-s2.0-0029566976 10.1016/0960-0760(95)00195-6 (Pubitemid 26022380)
74. Diederich S., Quinkler M., Miller K., Heilmann P., Schöneshöfer M., Oelkers W., Human kidney 11 β -hydroxy steroid dehydrogenase: regulation by adrenocorticotropin? European Journal of Endocrinology 1996 134 3 301 307 2-s2.0-0029670303
75. Quinkler M., Johanssen S., Großmann C., Bähr V., Müller M., Oelkers W., Diederich S., Progesterone metabolism in the human kidney and inhibition of 11 β -hydroxysteroid dehydrogenase type 2 by progesterone and its metabolites. The Journal of Clinical Endocrinology and Metabolism 1999 84 11 4165 4171 2-s2.0-0033331381 (Pubitemid 30644211)
76. Frühbeck G., Gómez-Ambrosi J., Muruzábal F. J., Burrell M. A., The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. American Journal of Physiology 2001 280 6 E827 E847 2-s2.0-0034987715 (Pubitemid 32553225)
77. Ronti T., Lupattelli G., Mannarino E., The endocrine function of adipose tissue: an update. Clinical Endocrinology 2006 64 4 355 365 2-s2.0-33644911756 10.1111/j.1365-2265.2006.02474.x
78. Campbell J. E., Peckett A. J., D'Souza A. M., Hawke T. J., Riddell M. C., Adipogenic and lipolytic effects of chronic glucocorticoid exposure. American Journal of Physiology 2011 300 1 C198 C209 2-s2.0-78651357560 10.1152/ajpcell.00045.2010
79. Fain J. N., Saperstein R., The involvement of RNA synthesis and cyclic AMP in the activation of fat cell lipolysis by growth hormone and glucocorticoids. Hormone and Metabolic Research 1970 2 2 27 2-s2.0-0014919827
80. Slavin B. G., Ong J. M., Kern P. A., Hormonal regulation of hormone-sensitive lipase activity and mRNA levels in isolated rat adipocytes. Journal of Lipid Research 1994 35 9 1535 1541 2-s2.0-0028037616 (Pubitemid 24291214)
81. Xu C., He J., Jiang H., Zu L., Zhai W., Pu S., Xu G., Direct effect of glucocorticoids on lipolysis in adipocytes. Molecular Endocrinology 2009 23 8 1161 1170 2-s2.0-67749088181 10.1210/me.2008-0464
82. Bujalska I. J., Kumar S., Hewison M., Stewart P. M., Differentiation of adipose stromal cells: the roles of glucocorticoids and 11 β -hydroxysteroid dehydrogenase. Endocrinology 1999 140 7 3188 3196 2-s2.0-0033305631 (Pubitemid 30650636)
83. Appel B., Fried S. K., Effects of insulin and dexamethasone on lipoprotein lipase in human adipose tissue. American Journal of Physiology 1992 262 5, part 1 E695 E699 2-s2.0-0026650744
84. Fried S. K., Russell C. D., Grauso N. L., Brolin R. E., Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men. Journal of Clinical Investigation 1993 92 5 2191 2198 2-s2.0-0027482040 (Pubitemid 23333523)
85. Strack A. M., Sebastian R. J., Schwartz M. W., Dallman M. F., Glucocorticoids and insulin: reciprocal signals for energy balance. American Journal of Physiology 1995 268 1, part 2 R142 R149 2-s2.0-0028813470
86. Lee I., Chiu Y., Hwu C., Central obesity is important but not essential component of the metabolic syndrome for predicting diabetes mellitus in a hypertensive family-based cohort. Cardiovascular Diabetology 2012 11, article 43
87. Bujalska I. J., Gathercole L. L., Tomlinson J. W., Darimont C., Ermolieff J., Fanjul A. N., Rejto P. A., Stewart P. M., A novel selective 11 β -hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis. Journal of Endocrinology 2008 197 2 297 307 2-s2.0-43849098723 10.1677/JOE-08-0050 (Pubitemid 351696242)
88. Seckl J. R., Morton N. M., Chapman K. E., Walker B. R., Glucocorticoids and 11beta-hydroxysteroid dehydrogenase in adipose tissue. Recent Progress in Hormone Research 2004 59 359 393 2-s2.0-2342427536
89. Talbott S., The Cortisol Connection: Why Stress Makes You Fat and Ruins Your Health-and What You Can Do About It 2007 Hunter House
90. Engeli S., Böhnke J., Feldpausch M., Gorzelniak K., Heintze U., Janke J., Luft F. C., Sharma A. M., Regulation of 11 β -HSD genes in human adipose tissue: influence of central obesity and weight loss. Obesity Research 2004 12 1 9 17 2-s2.0-1842552244 (Pubitemid 41137482)
91. Baron A. D., Brechtel G., Wallace P., Edelman S. V., Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. American Journal of Physiology 1988 255 6, part 2 E769 E774 2-s2.0-0024237258
92. Whorwood C. B., Donovan S. J., Flanagan D., Phillips D. I., Byrne C. D., Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome. Diabetes 2002 51 4 1066 1075 2-s2.0-0036230286
93. Morgan S. A., Sherlock M., Gathercole L. L., Lavery G. G., Lenaghan C., Bujalska I. J., Laber D., Yu A., Convey G., Mayers R., Hegyi K., Sethi J. K., Stewart P. M., Smith D. M., Tomlinson J. W., 11 β -hydroxysteroid dehydrogenase type 1 regulates glucocorticoid- induced insulin resistance in skeletal muscle. Diabetes 2009 58 11 2506 2515 2-s2.0-70350540686 10.2337/db09-0525
94. Ruzzin J., Wagman A. S., Jensen J., Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor. Diabetologia 2005 48 10 2119 2130 2-s2.0-26244462447 10.1007/s00125-005-1886-0 (Pubitemid 41416925)
95. Jang C., Obeyesekere V. R., Alford F. P., Inder W. J., Skeletal muscle 11 β hydroxysteroid dehydrogenase type 1 activity is upregulated following elective abdominal surgery. European Journal of Endocrinology 2009 160 2 249 255 2-s2.0-61449231714 10.1530/EJE-08-0619
96. Dovio A., Roveda E., Sciolla C., Montaruli A., Raffaelli A., Saba A., Calogiuri G., De Francia S., Borrione P., Salvadori P., Carandente F., Angeli A., Intense physical exercise increases systemic 11 β -hydroxysteroid dehydrogenase type 1 activity in healthy adult subjects. European Journal of Applied Physiology 2010 108 4 681 687 2-s2.0-77950861941 10.1007/s00421-009- 1265-5
97. Chen L. L., Hu X., Zheng J., Zhang H. H., Kong W., Yang W. H., Zeng T. S., Zhang J. Y., Yue L., Increases in energy intake, insulin resistance and stress in rats before Wenchuan earthquake far from the epicenter. Experimental Biology and Medicine 2010 235 10 1216 1223 2-s2.0-77957828415 10.1258/ebm.2010.010042
98. Coutinho A. E., Campbell J. E., Fediuc S., Riddell M. C., Effect of voluntary exercise on peripheral tissue glucocorticoid receptor content and the expression and activity of 11 β -HSD1 in the Syrian hamster. Journal of Applied Physiology 2006 100 5 1483 1488 2-s2.0-33646423263 10.1152/japplphysiol. 01236.2005
99. Borghouts L. B., Keizer H. A., Exercise and insulin sensitivity: a review. International Journal of Sports Medicine 2000 21 1 1 12 2-s2.0-0033967003 10.1055/s-2000-8847 (Pubitemid 30066077)
100. Benrick A., Wallenius V., Asterholm I. W., Interleukin-6 mediates exercise-induced increase in insulin sensitivity in mice. Experimental Physiology 2012 97 11 1224 1235 10.1113/expphysiol.2012.065508